Royan Stem Cell Technology Company, with nearly two decades of specialized activity in umbilical cord blood storage and regenerative medicine services, is the **first private and public umbilical cord blood stem cell bank in Iran**. It has collected close to **230,000 umbilical cord blood samples** from across the country. As the **largest umbilical cord blood bank in the Middle East**, this company utilizes the most advanced methods and medical equipment in the world for the collection, processing, testing, and preservation of umbilical cord blood and tissue stem cells.

It's been over three decades since the first umbilical cord blood transplant was performed to treat a child with Fanconi anemia. Today, umbilical cord blood is used to treat many malignant diseases like **blood disorders, immune system deficiencies, severe bone marrow failure, metabolic diseases, and some cancers**. Naturally, research in this field promises a future where umbilical cord blood cell usage will go beyond imagination. It's hoped that with the increasing trend of clinical trials worldwide, new applications will emerge for treating diseases such as **cerebral palsy, stroke, diabetes, and autism**.

To date, **over 50,000 umbilical cord blood transplants** have been performed worldwide for over 80 malignant and non-malignant diseases, with an efficacy rate of nearly 75%. Also, **over 8 million umbilical cord blood samples** have been stored in family and public cord blood banks globally. Leukemia is among the diseases where chemotherapy is often used to destroy cancerous blood cells, but this approach has side effects on the body's normal hematopoietic cells. Hematopoietic stem cell transplantation effectively replaces old, unhealthy cells with new, healthy ones.